Characterizing genetic architecture of clinical subtypes may accelerate targeted therapy
Many patients unnecessarily continue the medications for years
Pre-retirement reflections from a pioneering clinician, researcher and educator
Registry-based study is first to assess the issue in relation to cognition in epilepsy
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
ILAE advises emphasizing options for patients with drug-resistant epilepsy
Mounting support for the newly described microstructure from a 7T MRI and electroclinicopathologic study
Confirming the diagnosis is only the start of the journey
Communication is particularly critical in this often-misdiagnosed disorder
New Cleveland Clinic fellowship fosters expertise in the genetics of epilepsy
The neuroactive steroid significantly reduces seizures related to CDKL5 deficiency disorder